NCT04253834

Brief Summary

This study compares a novel breathing device, called the GO2 Mouthpiece, to the standard breathing tool called the incentive spirometer, thus improving respiratory dynamics of the postoperative patient.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 22, 2020

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 5, 2020

Completed
7 months until next milestone

Study Start

First participant enrolled

August 27, 2020

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2021

Completed
1 year until next milestone

Results Posted

Study results publicly available

February 15, 2022

Completed
Last Updated

February 15, 2022

Status Verified

January 1, 2022

Enrollment Period

5 months

First QC Date

January 22, 2020

Results QC Date

January 21, 2022

Last Update Submit

January 21, 2022

Conditions

Keywords

Cardiac surgeryCoronary bypassHeart valve replacementPostoperative pulmonary complications

Outcome Measures

Primary Outcomes (1)

  • Partial Pressure of Oxygen (PaO2 Level)

    Partial pressure of oxygen is a measurement of oxygen pressure in arterial blood. It reflects how well oxygen is able to move from the lungs to the blood. Normal values are 80 to 100 millimeters of mercury (mmHg).

    1, 6, 12 and 24 hours postextubation

Secondary Outcomes (7)

  • Number of Participants With Normal Atelectasis Score

    Immediately postoperative, Postoperative days 1, 2, 3, 4

  • Oxygen Requirement

    Postextubation Hours 1, 6, 12 and 24, Postoperative Days 2, 3, and 4

  • Carbon Dioxide Level

    Postextubation Hours 1, 6, 12 and 24

  • FEV1

    Preoperative and postoperative day 3

  • Forced Vital Capacity (FVC)

    Preoperative, Postoperative Day 3

  • +2 more secondary outcomes

Study Arms (2)

Incentive Spirometer Control Arm

ACTIVE COMPARATOR

Participants assigned to use the incentive spirometer after surgery.

Device: Incentive spirometer

GO2 Mouthpiece

EXPERIMENTAL

Participants assigned to use the Bidirectional Oxygenation Valve (GO2 Mouthpiece) after surgery.

Device: GO2 Mouthpiece

Interventions

The incentive spirometer is a device that measures how deeply a person can inhale (breathe in). It helps with taking slow, deep breaths to expand and fill the lungs with air, which helps prevent lung problems, such as pneumonia. The incentive spirometer is made up of a breathing tube, an air chamber, and an indicator to help users control their breathing.

Incentive Spirometer Control Arm

The GO2 Mouthpiece is a simple, comfortable, and straightforward silicone rubber-made, bidirectional oxygenation mouthpiece that effectively delivers PEEP with every breath.

Also known as: Bidirectional Oxygenation Valve
GO2 Mouthpiece

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Undergoing coronary artery bypass surgery (CABG) and/or valve replacement surgery
  • Able to provide written informed consent
  • Maintenance of an arterial line postoperatively

You may not qualify if:

  • Active smoking, within three months of surgery
  • Forced expiratory volume in one second (FEV1) \<75% predicted
  • Relative risk to develop pulmonary barotrauma as evident by history of pneumothorax or emphysema
  • Unable or unwilling to provide informed consent, cognitive impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emory Saint Joseph's Hospital

Atlanta, Georgia, 30342, United States

Location

Results Point of Contact

Title
Dr. Jeffrey Miller
Organization
Emory University

Study Officials

  • Jeffrey Miller, MD

    Emory University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Single center, prospective, randomized controlled study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

January 22, 2020

First Posted

February 5, 2020

Study Start

August 27, 2020

Primary Completion

January 31, 2021

Study Completion

January 31, 2021

Last Updated

February 15, 2022

Results First Posted

February 15, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Locations